Etiology of community-acquired pneumonia in hospitalized school-age children: evidence for high prevalence of viral infections

M N Tsolia, S Psarras, A Bossios, H Audi, M Paldanius, D Gourgiotis, K Kallergi, D A Kafetzis, A Constantopoulos, N G Papadopoulos, M N Tsolia, S Psarras, A Bossios, H Audi, M Paldanius, D Gourgiotis, K Kallergi, D A Kafetzis, A Constantopoulos, N G Papadopoulos

Abstract

Background: Community-acquired pneumonia (CAP) in young children is most commonly associated with viral infections; however, the role of viruses in CAP of school-age children is still inconclusive.

Methods: Seventy-five school-age children hospitalized with CAP were prospectively evaluated for the presence of viral and bacterial pathogens. Nasopharyngeal washes were examined by polymerase chain reaction for viruses and atypical bacteria. Antibody assays to detect bacterial pathogens in acute-phase and convalescent-phase serum samples were also performed.

Results: A viral infection was identified in 65% of cases. Rhinovirus RNA was detected in 45% of patients; infection with another virus occurred in 31%. The most common bacterial pathogen was Mycoplasma pneumoniae, which was diagnosed in 35% of cases. Chlamydia pneumoniae DNA was not detected in any patient; results of serological tests were positive in only 2 patients (3%). Mixed infections were documented in 35% of patients, and the majority were a viral-bacterial combination.

Conclusions: The high prevalence of viral and mixed viral-bacterial infections supports the notion that the presence of a virus, acting either as a direct or an indirect pathogen, may be the rule rather than the exception in the development of CAP in school-age children requiring hospitalization.

Figures

Table 1
Table 1
Infections caused by viruses and atypical bacteria diagnosed in 75 children (age, 5–14 years) hospitalized with community-acquired pneumonia.

References

    1. McIntosh K. Community-acquired pneumonia in children. N Engl J Med. 2002;346:429–37.
    1. British Thoracic Society. Guidelines for the management of community-acquired pneumonia in childhood. Thorax. 2002;57(Suppl 1):i1–24.
    1. Block S, Hedrick J, Hammerschlag MR, et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14:471–7.
    1. Harris JA, Kolokahtis A, Campbell M, Cassell G, Hammerschlag MR. Safety and efficacy of azithromycin in the treatment of community-acquired pneumonia. Pediatr Infect Dis J. 1998;17:865–71.
    1. Principi N, Esposito S, Blasi F, Allegra L. Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Mowgli Study Group. Clin Infect Dis. 2001;32:1281–9.
    1. Papadopoulos NG, Psarras S. Rhinoviruses in the pathogenesis of asthma. Curr Allergy Asthma Rep. 2003;3:137–45.
    1. Papadopoulos NG, Moustaki M, Tsolia M, et al. Association of rhinovirus infection with increased disease severity in acute bronchiolitis. Am J Respir Crit Care Med. 2002;165:1285–9.
    1. Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19:293–8.
    1. Xepapadaki P, Psarras S, Bossios A, et al. Human metapneumovirus as a causative agent of acute bronchiolitis in infants. J Clin Virol. 2004;30:267–70.
    1. Cunningham AF, Johnston SL, Julious SA, et al. Chronic Chlamydia pneumoniae infection and asthma exacerbations in children. Eur Respir J. 1998;11:345–9.
    1. Abele-Horn M, Busch U, Nitschko H, et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol. 1998;36:548–51.
    1. Ireland DC, Kent J, Nicholson KG. Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR. J Med Virol. 1993;40:96–101.
    1. Papadopoulos NG, Hunter J, Sanderson G, et al. Rhinovirus identification by BglI digestion of picornavirus RT-PCR amplicons. J Virol Methods. 1999;80:179–85.
    1. Wang S. The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation. J Infect Dis. 2000;181:421–5.
    1. Tuuminen T, Varjo S, Ingman H, Weber T, Oksi J, Viljanen M. Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays. Clin Diagn Lab Immunol. 2000;7:734–8.
    1. Ossewaarde JM, Tuuminen T, Boersma WG, Sandstrom M, Palomaki P, Boman J. A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies. J Microbiol Methods. 2000;43:117–25.
    1. Nohynek H, Eskola J, Kleemola M, Jalonen E, Saikku P, Leinonen M. Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J. 1995;14:478–84.
    1. Turner RB, Lande AE, Chase P, Hilton N, Weinberg D. Pneumonia in pediatric outpatients: cause and clinical manifestations. J Pediatr. 1987;111:194–200.
    1. Nohynek H, Eskola J, Laine E, et al. The causes of hospital treated lower respiratory tract infection in children. Am J Dis Child. 1991;145:618–22.
    1. Ruuskanen O, Nohynek H, Ziegler T, et al. Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis. 1992;11:217–23.
    1. Heiskanen-Kosma T, Korpi M, Jokinen C, et al. Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J. 1998;17:986–91.
    1. Wubbel L, Munitz L, Ahmed A, et al. Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J. 1999;18:98–104.
    1. Claesson BA, Trollfors B, Brolin I, et al. Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J. 1989;8:856–62.
    1. Papadopoulos NG, Johnston SL. Rhinoviruses as pathogens of the lower respiratory tract. Can Respir J. 2000;7:409–14.
    1. Papadopoulos NG, Sanderson G, Hunter J, Johnston SL. Rhinoviruses replicate effectively at lower airway temperatures. J Med Virol. 1999;58:100–4.
    1. Papadopoulos NG, Bates PJ, Bardin PG, et al. Rhinoviruses infect the lower airways. J Infect Dis. 2000;181:1875–84.
    1. Papadopoulos NG, Papi A, Meyer J, et al. Rhinovirus infection upregulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin Exp Allergy. 2001;31:1060–6.
    1. Chidekel AS, Rosen CL, Bazzy AR. Rhinovirus infection associated with serious lower respiratory tract illness in patients with bronchopulmonary dysplasia. Pediatr Infect Dis J. 1997;16:43–7.
    1. Krilov L, Pierik L, Keller E, et al. The association of rhinoviruses with lower respiratory tract disease in hodpitalized patients. J Med Virol. 1986;19:345–52.
    1. Schmidt HJ, Fink RJ. Rhinovirus as a lower respiratory tract pathogen in infants. Pediatr Infect Dis J. 1991;10:700–2.
    1. Kim JO, Hodinka RL. Serious respiratory illness associated with rhinovirus infection in a pediatric population. Clin Diagn Virol. 1998;10:57–65.
    1. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized children with “common cold” virus infections. Clin Infect Dis. 2000;31:96–100.
    1. Johnston SL, Sanderson G, Pattemore PK, et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol. 1993;31:111–7.
    1. Nokso-Koivisto J, Kinnari TJ, Lindahl P, et al. Human picornavirus and coronavirus RNA in nasopharynx of children without concurrent respiratory symptoms. J Med Virol. 2002;66:417–20.
    1. Gendrel D, Raymond J, Moulin JL, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis. 1997;16:388–91.
    1. Hardy RD, Michelow IC, Rios AM, et al. Program and abstracts of the 43rd Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago) Washington, DC: American Society for Microbiology; 2003. Comparison of nasopharyngeal and oropharyngeal PCR for the diagnosis of Mycoplasma pneumoniae pneumonia in children [abstract D-1859] p. 187.
    1. Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol. 2002;40:165–71.
    1. Waris ME, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol. 1998;36:3155–9.
    1. Triga MG, Anthracopoulos MB, Saikku P, Syrogiannopoulos GA. Chlamydia pneumoniae infection among healthy children and children hospitalized with pneumonia in Greece. Eur J Clin Microbiol Infect Dis. 2002;21:300–3.
    1. Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention. The American Thoracic Society. Am J Respir Crit Care Med. 2001;163:1730–54.
    1. Michelow IC, Lozano J, Olsen K, et al. Diagnosis of Streptococcus pneumoniae lower respiratory infection by culture, polymerase reaction, serological testing and urinary antigen detection. Clin Infect Dis. 2002;34:1–11.
    1. Vuori-Holopainen E, Salo E, Saxen H, et al. Etiological diagnosis of childhood pneumonia by use of transthoracic needle aspiration and modern microbiological methods. Clin Infect Dis. 2002;34:583–90.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir